Subscribe to RSS - Inogen


Law firm sues Inogen for misleading statements


SAN DIEGO – Robbins Geller Rudman & Dowd has filed a class action lawsuit against Inogen on behalf of purchasers of the company’s stock between Nov. 8, 2017, and Feb. 26, 2019.

Inogen’s DTC sales shine in Q4

B2B growth slows, however, due to reduction in orders from national provider

GOLETA, Calif. – 2018 was a “year of investment” for Inogen and it paid off, company officials say, with a 50.4% increase in direct-to-consumer sales in the fourth quarter

Inogen reports record sales year


GOLETA, Calif. – Inogen reported total revenues of $86.5 million for the fourth quarter of 2018, an increase of 35.7% over the same period in 2017. Sales revenues were $80.7 million and rental revenues were $5.8 million.

Law firm launches investigation, seeks info on Inogen


SAN DIEGO – Johnson Fistel, LLP, along with the California Deputy Attorney General, is investigating potential claims against Inogen for violations of state and federal securities laws in connection with statements the company made to the investing public.

Inogen launches connected platform


GOLETA, Calif. – Inogen has launched Inogen Connect, a wireless connectivity platform for its Inogen One G4 through its direct-to-consumer channel.

Inogen takes more ‘balanced approach’ to next POC

Company also preps to launch Inogen Connect, Inogen Capital

GOLETA, Calif. – Inogen teased three new products and services, including its next generation G5 portable oxygen concentrator, during a Nov. 6 conference call to discuss its financial results for the third quarter of 2018.

Earnings season: Inogen, BioScrip, VieMed


GOLETA, Calif. – Inogen reported $95.3 million in total revenue for the third quarter of 2018, a 38% increase over the same period last year.

In brief: GAO reports on bid program, Lifeway Mobility receives investment


WASHINGTON – The average reduction in payment rates in non-competitive bidding areas for five DME items with the highest expenditures in 2016 was 46%, according to a new report from the Government Accountability Office.

Inogen’s Scribner to leave


GOLETA, Calif. – Matt Scribner, Inogen’s executive vice president of operations, will leave the company, effective Jan. 2, 2019. Bart Sanford, most recently senior vice president of operations at Cepheid, a molecular diagnostics company, will step into the role on Sept.

Inogen watches as others follow suit


GOLETA, Calif. – It will only help Inogen that more manufacturers are deciding to raise awareness among consumers for their own POCs, CEO Scott Wilkinson says.